14. Human chorionic gonadotropin (hCG) is known to facilitate attachment of blastocyst to uterus. In women with mutation in hCG gene, biologically inactive hCG was formed but implantation occurred. When hcG was immune-neutralized in the uterus of normal woman,
implantation failed. This suggests that for implantation in humans:
(1) biologically active circulating hCG is not required.
(2) blastocyst can produce the required hCG, which helps locally in uterine attachment.
(3) trophoblastic cells do not require hCG for the invasion of uterus.
(4) extra-embryonic tissue is not responsible for the attachment of embryo to uterus

 

The process of blastocyst implantation into the uterus in humans involves complex molecular signaling, with human chorionic gonadotropin (hCG) playing a pivotal role. Scientific studies reveal that the blastocyst itself locally produces hCG, which acts in a paracrine manner to modulate the uterine environment and promote embryo attachment. If hCG is neutralized directly in the uterus, implantation fails, even in otherwise normal women, demonstrating that local hCG–not just circulating hormone—facilitates successful implantation.

Therefore, the right conclusion is:

(2) The blastocyst can produce the required hCG, which helps locally in uterine attachment.

---

---

Introduction

Embryo implantation marks one of the most crucial steps in human pregnancy. The attachment and invasion of the blastocyst into the endometrium depend on tightly regulated cross-talk between embryonic and uterine signals. Among these, human chorionic gonadotropin (hCG) stands out as a primary regulator, bridging maternal and embryonic processes.

---

Blastocyst-Produced hCG: Local Actions and Significance

• Upon arrival in the uterus, the blastocyst begins synthesizing and releasing hCG before it even enters maternal circulation.

• This localized hCG acts on the uterine lining, modulating the endometrium to enhance receptivity and promote tissue remodeling necessary for attachment.

• Direct neutralization of hCG within the uterus prevents implantation, even if systemic (circulating) hCG levels are normal, underscoring the importance of local action.

---

Mechanisms of hCG in Uterine Attachment

• hCG regulates the expression of growth factors, cytokines, and molecules such as galectin-3, HOXA-10, and VEGF that prime the endometrium for blastocyst invasion.

• It also supports angiogenesis and modulates immune responses, aiding maternal acceptance of the embryo.

• Local paracrine signals from the blastocyst ensure proper timing and orientation of these events, while circulating hCG supports ongoing pregnancy after implantation.

---

The Difference Between Local and Circulating hCG

• Mutations that result in biologically inactive circulating hCG do not necessarily block implantation if the blastocyst can locally produce active hormone to facilitate attachment.

• Only when hCG is neutralized at the site of implantation does the process fail, proving the key role of local hormone action.

---

Implications for Reproductive Health

• This understanding highlights new pathways for addressing implantation failures, especially in assisted reproductive technologies.

• Targeting local hCG action, rather than only systemic hormone levels, may enhance fertility treatments and outcomes.

---

Conclusion

Implantation in humans is critically dependent on local hCG produced by the blastocyst, which modulates the uterine environment for successful attachment. Circulating hCG supports later stages of pregnancy but is not solely responsible for implantation; local hormone action is vital.